Last updated: December 19, 2022
Sponsor: LMU Klinikum
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congestive Heart Failure
Treatment
N/AClinical Study ID
NCT05667519
PLACE
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- indication for right ventricular lead implantation according to current guidelines
Exclusion
Exclusion Criteria:
- preexisting tricuspid regurgitation ≥ grade 2
- other severe heart valve disease
- history of tricuspid valve treatment
- preexisting right ventricular lead
- chronic dialysis
- contraindication for transesophageal echocardiography
Study Design
Total Participants: 324
Study Start date:
October 01, 2022
Estimated Completion Date:
October 31, 2027
Study Description
Connect with a study center
LMU Klinikum
Munich, Bavaria 81377
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.